Pfizer Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending March 29, 2025: 3.67%

Pfizer Inc. Return on Assets (ROA) is 3.67% for the Trailing 12 Months (TTM) ending March 29, 2025, a -2,837.09% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.
  • Pfizer Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending March 31, 2024 was -0.13%, a -100.90% change year over year.
  • Pfizer Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending April 02, 2023 was 14.83%, a 6.11% change year over year.
  • Pfizer Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending April 03, 2022 was 13.98%, a 109.90% change year over year.
  • Pfizer Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending April 04, 2021 was 6.66%, a -30.16% change year over year.
Key Data
Date Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share Dividend Per Share